doi: 10.1007/BF00254030.
Cyclophosphamide and cis-dichlorodiammine platinum (11). Nonempiric scheduling to spare dose-limiting tissues in the rat
- PMID: 7190083
- DOI: 10.1007/BF00254030
Item in Clipboard
Cyclophosphamide and cis-dichlorodiammine platinum (11). Nonempiric scheduling to spare dose-limiting tissues in the rat
Cancer Chemother Pharmacol.
1980.
No abstract available
Similar articles
-
High-dose methotrexate with cyclophosphamide and cis-platinum in treatment of advanced ovarian carcinoma.Gynecol Oncol. 1979 Aug;8(1):74-7. doi: 10.1016/0090-8258(79)90009-x. Gynecol Oncol. 1979. PMID: 313358 No abstract available.
-
Chemotherapy for stage III-IV epithelial ovarian cancer with cis-dichlorodiammineplatinum(II), adriamycin, and cyclophosphamide: a preliminary report.Cancer Treat Rep. 1979 Feb;63(2):281-8. Cancer Treat Rep. 1979. PMID: 376134 Clinical Trial. No abstract available.
-
Comparative cytotoxic properties of ifosfamide and cyclophosphamide in rat solid tumor and normal tissues.Semin Oncol. 1982 Dec;9(4 Suppl 1):24-7. Semin Oncol. 1982. PMID: 7163812 No abstract available.
-
Prevention of cis-platinum nephrotoxicity in a high-risk patient.Ren Fail. 1996 Jul;18(4):691-5. doi: 10.3109/08860229609047697. Ren Fail. 1996. PMID: 8875699 Review.
-
Cisplatin (cis-diamminedichloroplatinum II).Cancer Treat Rev. 1979 Mar;6(1):17-39. doi: 10.1016/s0305-7372(79)80057-2. Cancer Treat Rev. 1979. PMID: 378370 Review. No abstract available.